2E9.SG Intervacc AB
Company Analysis
Latest News
π΄ Intervacc is trading 16.71% down today with no identified company-specific catalyst
Intervacc is trading 16.71% down at β¬0.06 after falling from recent β¬0.07 closes on September 21, 2026. - No credible company-specific announcement, earnings...
π΄ Intervacc is trading 15.99% down today with no clear catalyst identified
Intervacc is trading at β¬0.06 (-15.99%) after a sharp decline from recent β¬0.07 closes; no clear catalyst has been identified. β’ No confirmed company-specific...
π΄ Intervacc is trading 17.16% down today β no confirmed catalyst identified
Intervacc is trading at β¬0.06, down -17.16%, with no confirmed company-specific catalyst identified. - No company-specific announcement, earnings release,...
π΄ Intervacc is trading 18.14% down today amid weak biotech-sector sentiment
Intervacc is trading at β¬0.06 (-18.14%) after the September 16, 2026 session, with the decline appearing more consistent with weak biotech-sector sentiment...
π΄ Intervacc is trading 17.13% down today as biotech ETF XBI falls 2.11%
Intervacc is trading 17.13% down at β¬0.06 after a sharp decline during the September 15, 2026 session, amid broader biotech-sector weakness and fragile risk...
π’ Intervacc is trading 4.71% up on September 16, 2026 with no material catalyst identified
Intervacc is trading 4.71% up at β¬0.07 on September 16, 2026, with no material company-specific catalyst identified. - The move extends a rebound after the...
π’ Intervacc is trading 5.78% up today with no confirmed catalyst
Intervacc is trading at β¬0.07, up 5.78%, with no confirmed catalyst identified. - The company announced participation in the Swiss Nordic Bio Conference on...
π΄ Intervacc is trading 17.93% down with no confirmed catalyst
Intervacc is trading at β¬0.06 (-17.93%), with no confirmed company-specific catalyst identified. - No company-specific announcement dated September 11β14,...
π΄ Intervacc is trading 18.57% down β catalyst remains unidentified
Intervacc is trading 18.57% down at β¬0.06, after declining from β¬0.07 on September 8, 2026, with the catalyst remaining unidentified. - No verified...
π΄ Intervacc is trading 3.30% down today with no clear catalyst identified
Intervacc is trading at β¬0.07, down -3.30% on September 9, 2026, with no verified company-specific announcement dated September 9 explaining the move. - The...
π’ Intervacc is trading 18.47% up today, no verified catalyst identified
Intervacc is trading at β¬0.08 (+18.47%), with no verified company-specific announcement dated September 8, 2026 identified as the catalyst. - Recent disclosed...
π΄ Intervacc is trading 20.05% down today with no clear catalyst identified
Intervacc is trading 20.05% down at β¬0.06, with no clear company-specific catalyst identified for September 8, 2026. - The latest material developments were...
π΄ Intervacc is trading 4.14% down today β decline remains unexplained
Intervacc is trading at β¬0.08 (-4.14%), with no clear company-specific announcement identified for September 7, 2026; the decline remains unexplained. -...
π΄ Intervacc is trading 10.26% down today with no clear company-specific announcement identified
Intervacc is trading 10.26% down now at β¬0.07 after no clear company-specific announcement was identified for September 4, 2026. - Recent company coverage...
π’ Intervacc is trading 3.08% up on September 3, 2026 amid broader biotech strength
Intervacc is trading 3.08% up at β¬0.08, with the move appearing primarily driven by broader biotechnology-sector strength. - XBI was up 2.75% during the...
π΄ Intervacc is trading 14.9% down today β cause remains unclear
Intervacc is trading at β¬0.07, down 14.9%, after a sharp decline during the September 2, 2026 session; the cause remains unclear. - DNB Carnegieβs September 1...
Intervacc Gains DNB Carnegie Spotlight Following Recent News Flow
DNB Carnegie released a flash comment on Intervacc on September 1, 2026. The Nordic investment bank featured the biotechnology firm as part of its Micro Cap...
π΄ Intervacc is trading at 15.93% down today as biotech sector falls 4.24%
Intervacc is trading 15.93% down at β¬0.06 after broad biotech weakness and defensive risk reduction. - The biotechnology sector fell 4.24% during the regular...
π΄ Intervacc is trading 15.02% down today amid broad biotech weakness
Intervacc is trading 15.02% down now at β¬0.06 after broad biotech weakness and defensive risk reduction ahead of Federal Reserve Chair Kevin Warshβs Jackson...
π΄ Intervacc is trading 19.11% down today after sector-wide biotech weakness
Intervacc is trading 19.11% down now at β¬0.06 after sector-wide biotech weakness and risk reduction ahead of Federal Reserve Chair Kevin Warshβs Jackson Hole...